Entrada Therapeutics Rings the Closing Bell in Celebration of its IPO

Entrada Therapeutics (Nasdaq: TRDA), a biotechnology company aiming to transform the lives of patients by establishing Endosomal Escape Vehicle (EEVTM) therapeutics as a new class of medicines and aiming to become the world’s foremost intracellular therapeutics company, visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Dipal Doshi, President and Chief Executive Officer, rings the Closing Bell.